Table of Contents
ISRN Inflammation
Volume 2013 (2013), Article ID 191823, 13 pages
http://dx.doi.org/10.1155/2013/191823
Review Article

Atherosclerosis, Dyslipidemia, and Inflammation: The Significant Role of Polyunsaturated Fatty Acids

1Department of Laboratory Medicine, “Tor Vergata” University Hospital, Viale Oxford 81, 00133 Rome, Italy
2Nephrology and Hypertension Unit, Department of System Medicine, “Tor Vergata” University Hospital, Viale Oxford 81, 00133 Rome, Italy

Received 1 March 2013; Accepted 9 April 2013

Academic Editors: A. El-Shazly, D. Frommhold, F. M. Kovar, A. Merched, and D. Szukiewicz

Copyright © 2013 Mariarita Dessì et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Y. Abeywardena and G. S. Patten, “Role of ω3 longchain polyunsaturated fatty acids in reducing cardio-metabolic risk factors,” Endocrine, Metabolic and Immune Disorders, vol. 11, no. 3, pp. 232–246, 2011. View at Google Scholar · View at Scopus
  2. L. Dei Cas, S. Nodari, and A. Manerba, “Polyunsaturated fatty acids (n-3 PUFAs),” Giornale di Gerontologia, vol. 55, no. 1, pp. 45–57, 2007. View at Google Scholar · View at Scopus
  3. R. Ross, “Atherosclerosis and inflammatory disease,” New England Journal Medicine, vol. 340, pp. 115–126, 1999. View at Google Scholar
  4. F. Montecucco and F. Mach, “Atherosclerosis is an inflammatory disease,” in Seminars in Immunopathology, Springer, New York, NY, USA, 2009. View at Google Scholar
  5. U. N. Das, “A defect in the activity of Δ6 and Δ5 desaturases may be a factor in the initiation and progression of atherosclerosis,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 76, no. 5, pp. 251–268, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. U. N. Das, “Biological significance of essential fatty acids,” Journal of Association of Physicians of India, vol. 54, pp. 309–319, 2006. View at Google Scholar
  7. E. Patterson, R. Wall, G. F. Fitzgerald et al., “Health implications of high dietary Omega-6 polyunsaturated fatty acids,” Journal of Nutrition and Metabolism, vol. 5, pp. 1–16, 2012. View at Google Scholar
  8. G. Burdge, “α-Linolenic acid metabolism in men and women: nutritional and biological implications,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 7, no. 2, pp. 137–144, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. G. C. Burdge, Y. E. Finnegan, A. M. Minihane, C. M. Williams, and S. A. Wootton, “Effect of altered dietary n-3 fatty acid intake upon plasma lipid fatty acid composition, conversion of [13C]α-linolenic acid to longer-chain fatty acids and partitioning towards β-oxidation in older men,” British Journal of Nutrition, vol. 90, no. 2, pp. 311–321, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. G. C. Burdge, A. E. Jones, and S. A. Wootton, “Eicosapentanoic and docosapentanoic acids are the principal products of alpha-linoleic acid metabolism in young men,” British Journal of Nutrition, vol. 88, pp. 355–363, 2002. View at Google Scholar
  11. E. A. Emken, R. O. Adlof, and R. M. Gulley, “Dietary linoleic acid influences desaturation and acylation of deuterium-labeled linoleic and linolenic acids in young adult males,” Biochimica et Biophysica Acta, vol. 1213, no. 3, pp. 277–288, 1994. View at Publisher · View at Google Scholar · View at Scopus
  12. R. J. Pawlosky, J. R. Hibbeln, J. A. Novotny, and N. Salem, “Physiological compartmental analysis of α-linolenic acid metabolism in adult humans,” Journal of Lipid Research, vol. 42, no. 8, pp. 1257–1265, 2001. View at Google Scholar · View at Scopus
  13. P. L. L. Goyens, M. E. Spilker, P. L. Zock, M. B. Katan, and R. P. Mensink, “Compartmental modeling to quantify α-linolenic acid conversion after longer term intake of multiple tracer boluses,” Journal of Lipid Research, vol. 46, no. 7, pp. 1474–1483, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. U.S Department of Agriculture and U.S Department of Health and Human Services, Dietary Guidelines for Americans, Government Printing Office, Washington, DC, USA, 7th edition, 2010.
  15. C. R. Harper, M. J. Edwards, A. P. DeFilipis et al., “Flaxseed oil increases the plasma concentrations of cardioprotective (n-3) fatty acids in humans,” American Society For Nutrition, vol. 137, no. 2816, pp. 83–87, 2007. View at Google Scholar
  16. H. Truong, J. R. DiBello, E. Ruiz-Narvaez et al., “Does genetic variation in the Delta6-desaturase promoter modify the associatio between alpha-linolenic acid and the prevalence of metabolic syndrome?” The American Journal of Clinical Nutrition, vol. 89, pp. 920–925, 2009. View at Google Scholar
  17. S. N. Hansen and W. S. Harris, “New evidence for the cardiovascular benefits of long chain omega-3 fatty acids,” Current Atherosclerosis Reports, vol. 9, pp. 434–440, 2007. View at Google Scholar
  18. W. S. Harris, P. M. Kris-Etherton, and K. A. Harris, “Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults,” Current Atherosclerosis Reports, vol. 10, no. 6, pp. 503–509, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Mozaffarian, “Does alpha-linolenic acid intake reduce the risk of coronary heart disease? A review of the evidence,” Alternative Therapies in Health and Medicine, vol. 11, no. 3, pp. 24–31, 2005. View at Google Scholar · View at Scopus
  20. W. S. Harris, M. Miller, A. P. Tighe, M. H. Davidson, and E. J. Schaefer, “Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives,” Atherosclerosis, vol. 197, no. 1, pp. 12–24, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. GISSI Investigators, “Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nel'Infarto miocardico,” The Lancet, vol. 354, pp. 447–455, 1999. View at Google Scholar
  22. R. N. Lemaitre, I. B. King, D. Mozaffarian, L. H. Kuller, R. P. Tracy, and D. S. Siscovick, “n-3 polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the Cardiovascular Health Study,” American Journal of Clinical Nutrition, vol. 77, no. 2, pp. 319–325, 2003. View at Google Scholar · View at Scopus
  23. GISSI-HF investigators, “Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial,” The Lancet, vol. 372, no. 9645, pp. 1223–1230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Yokoyama, H. Origasa, M. Matsuzaki et al., “Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis,” The Lancet, vol. 369, no. 9567, pp. 1090–1098, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. D. Mozaffarian, “JELIS, fish oil, and cardiac events,” The Lancet, vol. 369, no. 9567, pp. 1062–1063, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. Mozaffarian, “Fish and n-3 fatty acids for the prevention of fatal coronary heart disease and sudden cardiac death,” American Journal of Clinical Nutrition, vol. 87, no. 6, pp. 1991S–1996S, 2008. View at Google Scholar · View at Scopus
  27. M. N. D. Di Minno, E. Tremoli, A. Tufano, A. Russolillo, R. Lupoli, and G. Di Minno, “Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective,” Thrombosis and Haemostasis, vol. 104, no. 4, pp. 664–680, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. M. Y. Abeywardena and R. J. Head, “Longchain n-3 polyunsaturated fatty acids and blood vessel function,” Cardiovascular Research, vol. 52, no. 3, pp. 361–371, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. G. C. Makris, G. Geroulakos, M. C. Makris, D. P. Mikhailidis, and M. E. Falagas, “The pleiotropic effects of statins and omega-3 fatty acids against sepsis: a new perspective,” Expert Opinion on Investigational Drugs, vol. 19, no. 7, pp. 809–814, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. P. P. Dimitrow and M. Jawien, “Pleiotropic, cardioprotective effects of omega-3 polyunsaturated fatty acids,” Mini-Reviews in Medicinal Chemistry, vol. 9, no. 9, pp. 1030–1039, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. S. C. Cottin, T. A. Sanders, and W. L. Hall, “The differential effects of EPA and DHA on cardiovascular risk factors,” Diabetes and Nutritional Sciences Division, School of Medicine, King’s College London, London, UK.
  32. Y. F. Xiao, A. M. Gomez, J. P. Morgan, W. J. Lederer, and A. Leaf, “Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 8, pp. 4182–4187, 1997. View at Google Scholar · View at Scopus
  33. G. R. Li, H. Y. Sun, X. H. Zhang et al., “Omega-3 polyunsaturated fatty acids inhibit transient outward and ultra-rapid delayed rectifier K+ currents and Na+ current in human atrial myocytes,” Cardiovascular Research, vol. 81, no. 2, pp. 286–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. Y. F. Xiao, D. C. Sigg, and A. Leaf, “The antiarrhythmic effect of n-3 polyunsaturated fatty acids: modulation of cardiac ion channels as a potential mechanism,” Journal of Membrane Biology, vol. 206, no. 2, pp. 141–154, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. J. X. Kang and A. Leaf, “Evidence that free polyunsaturated fatty acids modify Na+ channels by directly binding to the channel proteins,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 8, pp. 3542–3546, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. P. L. McLennan, “Myocardial membrane fatty acids and the antiarrhythmic actions of dietary fish oil in animal models,” Lipids, vol. 36, supplement, pp. S111–S114, 2001. View at Google Scholar · View at Scopus
  37. T. A. Mori, D. Q. Bao, V. Burke, I. B. Puddey, and L. J. Beilin, “Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans,” Hypertension, vol. 34, no. 2, pp. 253–260, 1999. View at Google Scholar · View at Scopus
  38. A. Grynberg, A. Fournier, J. P. Sergiel, and P. Athias, “Effect of docosahexaenoic acid and eicosapentaenoic acid in the phospholipids of rat heart muscle cells on adrenoceptor responsiveness and mechanism,” Journal of Molecular and Cellular Cardiology, vol. 27, no. 11, pp. 2507–2520, 1995. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Hashimoto, K. Shinozuka, S. Gamoh et al., “The hypotensive effect of docosahexaenoic acid is associated with the enhanced release of ATP from the caudal artery of aged rats,” Journal of Nutrition, vol. 129, no. 1, pp. 70–76, 1999. View at Google Scholar · View at Scopus
  40. D. Mozaffarian, A. Geelen, I. A. Brouwer, J. M. Geleijnse, P. L. Zock, and M. B. Katan, “Effect of fish oil on heart rate in humans: a meta-analysis of randomized controlled trials,” Circulation, vol. 112, no. 13, pp. 1945–1952, 2005. View at Publisher · View at Google Scholar · View at Scopus
  41. K. D. Stark and B. J. Holub, “Differential eicosapentaenoic acid elevations and altered cardiovascular disease risk factor responses after supplementation with docosahexaenoic acid in postmenopausal women receiving and not receiving hormone replacement therapy,” American Journal of Clinical Nutrition, vol. 79, no. 5, pp. 765–773, 2004. View at Google Scholar · View at Scopus
  42. S. Grimsgaard, K. H. Bønaa, J. B. Hansen, and E. S. P. Myhre, “Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans,” American Journal of Clinical Nutrition, vol. 68, no. 1, pp. 52–59, 1998. View at Google Scholar · View at Scopus
  43. R. J. Woodman, T. A. Mori, V. Burke, I. B. Puddey, G. F. Watts, and L. J. Beilin, “Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension,” American Journal of Clinical Nutrition, vol. 76, no. 5, pp. 1007–1015, 2002. View at Google Scholar · View at Scopus
  44. J. H. Christensen, H. A. Skou, L. Fog et al., “Marine n-3 fatty acids, wine intake, and heart rate variability in patients referred for coronary angiography,” Circulation, vol. 103, no. 5, pp. 651–657, 2001. View at Google Scholar · View at Scopus
  45. F. Holguin, M. M. Téllez-Rojo, M. Lazo et al., “Cardiac autonomic changes associated with fish oil vs soy oil supplementation in the elderly,” Chest, vol. 127, no. 4, pp. 1102–1107, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. J. H. Christensen, M. S. Christensen, J. Dyerberg, and E. B. Schmidt, “Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids,” American Journal of Clinical Nutrition, vol. 70, no. 3, pp. 331–337, 1999. View at Google Scholar · View at Scopus
  47. J. M. Geleijnse, J. De Goede, and I. A. Brouwer, “Alpha-linolenic acid: is it essential to cardiovascular health?” Current Atherosclerosis Reports, vol. 12, no. 6, pp. 359–367, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Dodin, S. C. . Cunnane, B. Mâsse et al., “Flaxseed on cardio-vascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial,” Nutrition, vol. 24, pp. 23–30, 2008. View at Google Scholar
  49. H. Campos, A. Baylin, and W. C. . Willett, “Alpha-linolenic acid and risk of nonfatal acute myocardial infarction,” Circulation, vol. 118, pp. 339–345, 2008. View at Google Scholar
  50. A. Sala-Vila, M. Cofán, A. Pérez-Heras et al., “Fatty acids in serum phospholipids and carotid intima-media thickness in Spanish subjects with primary dyslipidemia,” The American Journal of Clinical Nutrition, vol. 92, pp. 186–193, 2010. View at Google Scholar
  51. Y. Park, J. Lim, Y. Kwon, and J. Lee, “Correlation of erythrocyte fatty acid composition and dietary intakes with markers of atherosclerosis in patients with myocardial infarction,” Nutrition Research, vol. 29, no. 6, pp. 391–396, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. E. Warensjö, J. Sundström, B. Vessby, T. Cederholm, and U. Risérus, “Markers of dietary fat quality and fatty acid desaturation as predictors of total and cardiovascular mortality: a population-based prospective study,” American Journal of Clinical Nutrition, vol. 88, no. 1, pp. 203–209, 2008. View at Google Scholar · View at Scopus
  53. R. N. Lemaitre, I. B. King, N. Sotoodehnia et al., “Red blood cell membrane α-linolenic acid and the risk of sudden cardiac arrest,” Metabolism, vol. 58, no. 4, pp. 534–540, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. W. S. Harris and D. Bulchandani, “Why do omega-3 fatty acids lower serum triglycerides?” Current Opinion in Lipidology, vol. 17, no. 4, pp. 387–393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. D. Faeh, K. Minehira, J. M. Schwarz et al., “Effect of fructose overfeeding and fish oil administration on hepatic de novo lipogenesis and insulin sensitivity in healthy men,” Diabetes, vol. 54, no. 1, pp. 907–913, 2005. View at Google Scholar
  56. S. D. Clarke, “Polyunsaturated fatty acid regulation of gene transcription: a molecular mechanism to improve the metabolic syndrome,” Journal of Nutrition, vol. 131, no. 4, pp. 1129–1132, 2001. View at Google Scholar · View at Scopus
  57. A. A. Rivellese, A. Maffettone, C. Iovine et al., “Long-term effects of fish oil on insulin resistance and plasma lipoproteins in NIDDM patients with hypertriglyceridemia,” Diabetes Care, vol. 19, no. 11, pp. 1207–1213, 1996. View at Google Scholar · View at Scopus
  58. V. Saraswathi, J. D. Morrow, and A. H. Hasty, “Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR-/- mice,” Journal of Nutrition, vol. 139, no. 12, pp. 2380–2386, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. D. B. Jump, “Fatty acid regulation of hepatic lipid metabolism,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 14, no. 2, pp. 115–120, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Wada, T. Yamazaki, Y. Kawano, S. Miura, and O. Ezaki, “Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice,” Journal of Hepatology, vol. 49, no. 3, pp. 441–450, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Kobatake, K. Kuroda, and H. Jinnouchi, “Differential effects of dietary eicosapentaenoic and docosahexaenoic fatty acids on lowering of triglyceride and cholesterol levels in the serum of rats on hypercholesterolemic diet,” Journal of Nutritional Science and Vitaminology, vol. 30, no. 4, pp. 357–372, 1984. View at Google Scholar · View at Scopus
  62. G. S. Rambjør, A. I. Wålen, S. L. Windsor, and W. S. Harris, “Eicosapentaenoic acid is primarily responsible for hypotriglyceridemic effect of fish oil in humans,” Lipids, vol. 31, no. 3, supplement, pp. S45–S49, 1996. View at Google Scholar · View at Scopus
  63. T. Terano, T. Kojima, A. Seya et al., “The effect of highly purified eicosapentaenoic acid in patients with psoriasis,” Advance Prostaglandin, Thromboxane, and Leukotriene Research, vol. 19, pp. 610–613, 1989. View at Google Scholar · View at Scopus
  64. A. Hirai, T. Terano, H. Makuta et al., “Effect of oral administration of highly purified eicosapentaenoic acid and docosahexaenoic acid on platelet function and serum lipids in hyperlipidemic patients,” Advance Prostaglandin, Thromboxane, and Leukotriene Research, vol. 19, pp. 627–630, 1989. View at Google Scholar · View at Scopus
  65. R. Buckley, B. Shewring, R. Turner, P. Yaqoob, and A. M. Minihane, “Circulating triacylglycerol and apoE levels in response to EPA and docosahexaenoic acid supplementation in adult human subjets,” British Journal of Nutrition, vol. 92, no. 3, pp. 477–483, 2004. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Park and W. S. Harris, “Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance,” Journal of Lipid Research, vol. 44, no. 3, pp. 455–463, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Grimsgaard, K. H. Bønaa, J. B. Hansen, and A. Nordøy, “Highly purified eicosapentaenoic acid and docosahexaenoic acid in humans have similar triacylglycerol-lowering effects but divergent effects on serum fatty acids,” American Journal of Clinical Nutrition, vol. 66, no. 3, pp. 649–659, 1997. View at Google Scholar · View at Scopus
  68. S. Egert, F. Kannenberg, V. Somoza, H. F. Erbersdobler, and U. Wahrburg, “Dietary α-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans,” Journal of Nutrition, vol. 139, no. 5, pp. 861–868, 2009. View at Publisher · View at Google Scholar · View at Scopus
  69. T. A. Mori, V. Burke, I. B. Puddey et al., “Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hypedipidemic men,” American Journal of Clinical Nutrition, vol. 71, no. 5, pp. 1085–1094, 2000. View at Google Scholar · View at Scopus
  70. E. Olano-Martin, E. Anil, M. J. Caslake et al., “Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil,” Atherosclerosis, vol. 209, no. 1, pp. 104–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. R. J. Woodman, T. A. Mori, V. Burke, I. B. Puddey, G. F. Watts, and L. J. Beilin, “Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension,” American Journal of Clinical Nutrition, vol. 76, no. 5, pp. 1007–1015, 2002. View at Google Scholar · View at Scopus
  72. P. Nestel, H. Shige, S. Pomeroy, M. Cehun, M. Abbey, and D. Raederstorff, “The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans,” American Journal of Clinical Nutrition, vol. 76, no. 2, pp. 326–330, 2002. View at Google Scholar · View at Scopus
  73. W. S. Harris, “n-3 fatty acids and serum lipoproteins: human studies,” The American Journal of Clinical Nutrition, vol. 65, pp. 1645S–1654S, 1997. View at Google Scholar
  74. B. De Roos, Y. Mavrommatis, and I. A. Brouwer, “Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease,” British Journal of Pharmacology, vol. 158, no. 2, pp. 413–428, 2009. View at Publisher · View at Google Scholar · View at Scopus
  75. D. C. Goff, A. G. Bertoni, H. Kramer et al., “Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium,” Circulation, vol. 113, no. 5, pp. 647–656, 2006. View at Publisher · View at Google Scholar · View at Scopus
  76. K. M. Anderson, W. P. Castelli, and D. Levy, “Cholesterol and mortality. 30 Years of follow-up from the Framingham Study,” Journal of the American Medical Association, vol. 257, no. 16, pp. 2176–2180, 1987. View at Google Scholar · View at Scopus
  77. A. A. Liakishev, “Correction of lipid disorders in patients with arterial hypertension,” Russian Medical Journals, vol. 10, no. 19, pp. 878–882, 2002. View at Google Scholar
  78. J. D. Kobalava and V. V. Tolkachev, “Hypercholesterolemia and arterial hypertension,” Heart, vol. 4, no. 28, pp. 172–176, 2006. View at Google Scholar
  79. T. P. Novgorodtseva, T. A. Kantur, Y. K. Karaman, M. V. Antonyuk, and N. V. Zhukova, “Modification of fatty acids composition in erythrocytes lipids in arterial hypertension associated with dyslipidemia,” Lipids in Health and Disease, vol. 10, article 18, 2011. View at Publisher · View at Google Scholar · View at Scopus
  80. D. C. Goff, A. G. Bertoni, H. Kramer et al., “Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium,” Circulation, vol. 113, no. 5, pp. 647–656, 2006. View at Publisher · View at Google Scholar · View at Scopus
  81. D. K. Arnett, D. R. Jacobs, R. V. Luepker, H. Blackburn, C. Armstrong, and S. A. Claas, “Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980–1982 to 2000–2002,” Circulation, vol. 112, no. 25, pp. 3884–3891, 2005. View at Publisher · View at Google Scholar · View at Scopus
  82. I. Graham, M. T. Cooney, D. Bradley, A. Dudina, and Z. Reiner, “Dyslipidemias in the prevention of cardiovascular disease: risks and causality,” Current Cardiology Reports, vol. 14, no. 6, pp. 709–720, 2012. View at Publisher · View at Google Scholar
  83. S. Y. Martsevich, “Treatment of lipid disorders in patients with coronary heart disease,” Treating Physician, vol. 5, pp. 42–45, 2005. View at Google Scholar
  84. E. A. Endakova and T. P. Novgorodtseva, Svetashev VI Modification of Blood Fatty Acids Composition in Case of Cardiovascular Diseases, vol. 296, Dalnauka, Vladivostok, Russia, 2002.
  85. V. N. Titov, “Atherosclerosis as a pathology polien fatty acids,” in Biological Bases Pathogenesis, Diagnostics, Preventive and Treatment of Atherosclerosis, vol. 750, M:Altus, 2002. View at Google Scholar
  86. S. Rizza, M. Tesauro, C. Cardillo et al., “Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetes,” Atherosclerosis, vol. 206, no. 2, pp. 569–574, 2009. View at Publisher · View at Google Scholar · View at Scopus
  87. T. A. Mori, “Omega-3 fatty acids and hypertension in humans,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 9, pp. 842–846, 2006. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Wang, A. Q. Ma, S. W. Song, Q. H. Quan, X. F. Zhao, and X. H. Zheng, “Fish oil supplementation improves large arterial elasticity in overweight hypertensive patients,” European Journal of Clinical Nutrition, vol. 62, no. 12, pp. 1426–1431, 2008. View at Publisher · View at Google Scholar · View at Scopus
  89. D. Ait-Yahia, S. Madani, J. L. Savelli, J. Prost, M. Bouchenak, and J. Belleville, “Dietary fish protein lowers blood pressure and alters tissue polyunsaturated fatty acid composition in spontaneously hypertensive rats,” Nutrition, vol. 19, no. 4, pp. 342–346, 2003. View at Publisher · View at Google Scholar · View at Scopus
  90. A. T. Erkkilä, U. S. Schwab, V. D. F. De Mello et al., “Effects of fatty and lean fish intake on blood pressure in subjects with coronary heart disease using multiple medications,” European Journal of Nutrition, vol. 47, no. 6, pp. 319–328, 2008. View at Publisher · View at Google Scholar · View at Scopus
  91. S. Taddei, L. Ghiadoni, A. Virdis, D. Versari, and A. Salvetti, “Mechanisms of endothelial dysfunction: clinical significance and preventive non-pharmacological therapeutic strategies,” Current Pharmaceutical Design, vol. 9, no. 29, pp. 2385–2402, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. C. L. Stebbins, J. P. Stice, C. M. Hart, F. N. Mbai, and A. A. Knowlton, “Effects of dietary decosahexaenoic acid (DHA) on eNOS in human coronary artery endothelial cells,” Journal of Cardiovascular Pharmacology and Therapeutics, vol. 13, no. 4, pp. 261–268, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. R. De Caterina, M. Massaro, E. Scoditti, and M. Annunziata Carluccio, “Pharmacological modulation of vascular inflammation in atherothrombosis,” Annals of the New York Academy of Sciences, vol. 1207, pp. 23–31, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. R. Ross, “Phathogenesis of atherosclerosis a prospective for the 1990s,” Nature, vol. 362, pp. 801–809, 1993. View at Google Scholar
  95. J. H. Qiao, J. Tripathi, N. K. Mishra et al., “Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice,” American Journal of Pathology, vol. 150, no. 5, pp. 1687–1699, 1997. View at Google Scholar · View at Scopus
  96. J. Bernhagen, R. Krohn, H. Lue et al., “MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment,” Nature Medicine, vol. 13, no. 5, pp. 587–596, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. P. Libby, “Vascular biology of atherosclerosis: overview and state of the art,” American Journal of Cardiology, vol. 91, no. 3, pp. 3A–6A, 2003. View at Publisher · View at Google Scholar · View at Scopus
  98. F. M. van der Valk, D. F. van Wijk, and E. S. G. Stroes, “Novel anti-inflammatory strategies in atherosclerosis,” Current Opinion in Lipidology, vol. 23, pp. 532–539, 2012. View at Google Scholar
  99. A. Stirban, S. Nandrean, C. Götting et al., “Effects of n-3 fatty acids on macro- and microvascular function in subjects with type 2 diabetes mellitus,” American Journal of Clinical Nutrition, vol. 91, no. 3, pp. 808–813, 2010. View at Publisher · View at Google Scholar · View at Scopus
  100. F. Dangardt, W. Osika, Y. Chen et al., “Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents,” Atherosclerosis, vol. 212, no. 2, pp. 580–585, 2010. View at Publisher · View at Google Scholar · View at Scopus
  101. J. Goodfellow, M. F. Bellamy, M. W. Ramsey, C. J. H. Jones, and M. J. Lewis, “Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia,” Journal of the American College of Cardiology, vol. 35, no. 2, pp. 265–270, 2000. View at Publisher · View at Google Scholar · View at Scopus
  102. M. M. Engler, M. B. Engler, M. Malloy et al., “Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the early study,” International Journal of Clinical Pharmacology and Therapeutics, vol. 42, no. 12, pp. 672–679, 2004. View at Google Scholar · View at Scopus
  103. M. Haberka, K. Mizia-Stec, M. Mizia et al., “N-3 polyunsaturated fatty acids early supplementation improves ultrasound indices of endothelial function, but not through NO inhibitors in patients with acute myocardial infarction. N-3 PUFA supplementation in acute myocardial infarction,” Clinical Nutrition, vol. 30, no. 1, pp. 79–85, 2011. View at Publisher · View at Google Scholar · View at Scopus
  104. V. Schiano, E. Laurenzano, G. Brevetti et al., “Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function,” Clinical Nutrition, vol. 27, no. 2, pp. 241–247, 2008. View at Publisher · View at Google Scholar · View at Scopus
  105. H. Tagawa, H. Shimokawa, T. Tagawa, M. Kuroiwa-Matsumoto, Y. Hirooka, and A. Takeshita, “Long-term treatment with eicosapentaenoic acid augments both nitric oxide-mediated and non-nitric oxide-mediated endothelium-dependent forearm vasodilatation in patients with coronary artery disease,” Journal of Cardiovascular Pharmacology, vol. 33, no. 4, pp. 633–640, 1999. View at Publisher · View at Google Scholar · View at Scopus
  106. S. N. Doshi, K. K. Naka, N. Payne et al., “Flow-mediated dilatation following wrist and upper arm occlusion in humans: the contribution of nitric oxide,” Clinical Science, vol. 101, no. 6, pp. 629–635, 2001. View at Publisher · View at Google Scholar · View at Scopus
  107. W. S. Harris, G. S. Rambjor, S. L. Windsor et al., “N-3 fatty acids and urinary excretion of nitric oxide metabolites in humans,” The Amrican Journal of Clinical Nutrition, vol. 65, pp. 459–464, 1997. View at Google Scholar
  108. Y. Okuda, K. Kawashima, T. Sawada et al., “Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells,” Biochemical and Biophysical Research Communications, vol. 232, no. 2, pp. 487–491, 1997. View at Publisher · View at Google Scholar · View at Scopus
  109. M. Omura, S. Kobayashi, Y. Mizukami et al., “Eicosapentaenoic acid (EPA) induces Ca2+-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxation,” FEBS Letters, vol. 487, no. 3, pp. 361–366, 2001. View at Publisher · View at Google Scholar · View at Scopus
  110. T. U. Singh, K. Kathirvel, S. Choudhury, S. K. Garg, and S. K. Mishra, “Eicosapentaenoic acid-induced endothelium-dependent and -independent relaxation of sheep pulmonary artery,” European Journal of Pharmacology, vol. 636, no. 1–3, pp. 108–113, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. D. López, M. Möller, A. Denicola et al., “Long-chain n-3 polyunsaturated fatty acid from fish oil modulates aortic nitric oxide and tocopherol status in the rat,” British Journal of Nutrition, vol. 100, no. 4, pp. 767–775, 2008. View at Publisher · View at Google Scholar · View at Scopus
  112. J. G. Robinson and N. J. Stone, “Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids,” American Journal of Cardiology, vol. 98, no. 4, pp. 39–49, 2006. View at Publisher · View at Google Scholar · View at Scopus
  113. P. M. Kris-Etherton, W. S. Harris, and L. J. Appel, “Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease,” Circulation, vol. 106, no. 21, pp. 2747–2757, 2002. View at Publisher · View at Google Scholar · View at Scopus
  114. F. Thies, J. M. C. Garry, P. Yaqoob et al., “Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial,” The Lancet, vol. 361, no. 9356, pp. 477–485, 2003. View at Publisher · View at Google Scholar · View at Scopus
  115. D. Mozaffarian and J. H. Wu, “Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events,” Journal of the American College of Cardiology, vol. 58, no. 20, pp. 2047–2068, 2011. View at Google Scholar
  116. S. P. Tull, C. M. Yates, B. H. Maskrey et al., “Omega-3 fatty acids and inflammation: novel interactions reveal a new step in neutrophil recruitment,” PLoS Biology, vol. 7, no. 8, Article ID e1000177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  117. T. Hamada, S. Tsuchihashi, A. Avanesyan et al., “Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury,” Journal of Immunology, vol. 180, no. 3, pp. 1843–1853, 2008. View at Google Scholar · View at Scopus
  118. V. L. Gonçalves De Moraes, B. B. Vargaftig, J. Lefort, A. Meager, and M. Chignard, “Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung,” British Journal of Pharmacology, vol. 117, no. 8, pp. 1792–1796, 1996. View at Google Scholar · View at Scopus
  119. J. E. Beesley, J. D. Pearson, and A. Hutchings, “Granulocyte migration through endothelium in culture,” Journal of Cell Science, vol. 38, pp. 237–248, 1979. View at Google Scholar · View at Scopus
  120. J. D. Pearson, J. S. Carleton, and J. E. Beesley, “Granylocyte adhesion to endothelium in culture,” Journal of Cell Science, vol. 38, pp. 225–235, 1979. View at Google Scholar · View at Scopus
  121. Y. Fujitani, Y. Kanaoka, K. Aritake, N. Uodome, K. Okazaki-Hatake, and Y. Urade, “Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice,” Journal of Immunology, vol. 168, no. 1, pp. 443–449, 2002. View at Google Scholar · View at Scopus
  122. R. Rajakariar, M. Hilliard, T. Lawrence et al., “Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyΔ12-14 PGJ2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 52, pp. 20979–20984, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. Y. Isobe, T. Kato, and M. Arita, “Emerging roles of eosinophils and eosinophil derived lipid mediators in the resolution of inflammation,” Frontiers in Immunology, vol. 3, article 270, 2012. View at Google Scholar
  124. C. N. Serhan, C. B. Clish, J. Brannon et al., “Novel functional sets of lipid-derived mediators with antiinflammatory actions generated fromomega-3fatty acids via cyclooxygenase2-nonsteroidal antiinflammatory drugs and tran-scellular processing,” The Journal of Experimental Medicine, vol. 192, pp. 1197–1204, 2000. View at Google Scholar
  125. M. Arita, F. Bianchini, J. Aliberti et al., “Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1,” Journal of Experimental Medicine, vol. 201, no. 5, pp. 713–722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  126. E. Tjonahen, S. F. Oh, J. Siegelman et al., “Resolvin E2: identification and anti-inflammatory actions. Pivotal roleof human 5-lipoxygenasein resolvin Eseries biosynthesis,” Chemistry and Biology, vol. 13, no. 11, pp. 1193–1202, 2006. View at Publisher · View at Google Scholar · View at Scopus
  127. C. N. Serhan, S. Hong, K. Gronert et al., “Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals,” Journal of Experimental Medicine, vol. 196, no. 8, pp. 1025–1037, 2002. View at Publisher · View at Google Scholar · View at Scopus
  128. Y. P. Sun, S. F. Oh, J. Uddin et al., “Resolvin D1 and its aspirin-triggered 17R epimer: stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation,” Journal of Biological Chemistry, vol. 282, no. 13, pp. 9323–9334, 2007. View at Publisher · View at Google Scholar · View at Scopus
  129. M. Spite, L. V. Norling, L. Summers et al., “Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis,” Nature, vol. 461, no. 7268, pp. 1287–1291, 2009. View at Publisher · View at Google Scholar · View at Scopus
  130. N. Chiang, G. Fredman, F. Bäckhed et al., “Infection regulates pro-resolving mediators that lower antibiotic requirements,” Nature, vol. 484, pp. 524–528, 2012. View at Google Scholar
  131. S. Hong, K. Gronert, P. R. Devchand, R. L. Moussignac, and C. N. Serhan, “Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells: autacoids in anti-inflammation,” Journal of Biological Chemistry, vol. 278, no. 17, pp. 14677–14687, 2003. View at Publisher · View at Google Scholar · View at Scopus
  132. V. L. Marcheselli, S. Hong, W. J. Lukiw et al., “Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression,” The Journal of Biological Chemistry, vol. 278, pp. 43807–43817, 2003. View at Google Scholar
  133. C. N. Serhan, K. Gotlinger, S. Hong et al., “Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes,” The Journal of Immunology, vol. 176, pp. 1848–1859, 2006. View at Google Scholar
  134. C. N. Serhan, R. Yang, K. Martinod et al., “Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions,” Journal of Experimental Medicine, vol. 206, no. 1, pp. 15–23, 2009. View at Publisher · View at Google Scholar · View at Scopus
  135. C. N. Serhan, J. Dalli, S. Karamnov et al., “Macrophage proresolving mediator maresin1 stimulates tissuere generation and controls pain,” The FASEB Journal, vol. 26, pp. 1755–1765, 2012. View at Google Scholar
  136. A. Ariel, G. Fredman, Y. P. Sun et al., “Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression,” Nature Immunology, vol. 7, no. 11, pp. 1209–1216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  137. J. M. Schwab, N. Chiang, M. Arita, and C. N. Serhan, “Resolvin E1 and protectin D1 activate inflammation-resolution programmes,” Nature, vol. 447, no. 7146, pp. 869–874, 2007. View at Publisher · View at Google Scholar · View at Scopus
  138. S. F. Oh, P. S. Pillai, A. Recchiuti, R. Yang, and C. N. Serhan, “Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation,” Journal of Clinical Investigation, vol. 121, no. 2, pp. 569–581, 2011. View at Publisher · View at Google Scholar · View at Scopus
  139. A. Leaf and P. C. Weber, “Cardiovascular effects of n-3 fatty acids,” New England Journal of Medicine, vol. 318, no. 9, pp. 549–557, 1988. View at Google Scholar · View at Scopus
  140. R. De Caterina and A. Zampolli, “n-3 fatty acids: antiatherosclerotic effects,” Lipids, vol. 36, supplement, pp. S69–S78, 2001. View at Google Scholar · View at Scopus
  141. K. He, K. Liu, M. L. Daviglus et al., “Associations of Dietary Long-Chain n-3 Polyunsaturated Fatty Acids and Fish With Biomarkers of Inflammation and Endothelial Activation (from the Multi-Ethnic Study of Atherosclerosis [MESA]),” American Journal of Cardiology, vol. 103, no. 9, pp. 1238–1243, 2009. View at Publisher · View at Google Scholar · View at Scopus
  142. P. M. Ridker, C. H. Hennekens, J. E. Buring, and N. Rifai, “C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women,” New England Journal of Medicine, vol. 342, no. 12, pp. 836–843, 2000. View at Publisher · View at Google Scholar · View at Scopus
  143. T. C. Wu, H. B. Leu, W. T. Lin, C. P. Lin, S. J. Lin, and J. W. Chen, “Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease,” European Journal of Clinical Investigation, vol. 35, no. 9, pp. 537–545, 2005. View at Publisher · View at Google Scholar · View at Scopus
  144. S. Nanni, G. Melandri, R. Hanemaaijer et al., “Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms,” Translational Research, vol. 149, no. 3, pp. 137–144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  145. M. C. Bourdillon, R. N. Poston, C. Covacho, E. Chignier, G. Bricca, and J. L. McGregor, “ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE(-/-)/ICAM-1(-/-)) fed a fat or a chow diet,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 12, pp. 2630–2635, 2000. View at Google Scholar · View at Scopus
  146. P. M. Ridker, C. H. Hennekens, B. Roitman-Johnson, M. J. Stampfer, and J. Allen, “Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men,” The Lancet, vol. 351, no. 9096, pp. 88–92, 1998. View at Publisher · View at Google Scholar · View at Scopus
  147. K. K. Ray, D. A. Morrow, A. Shui, N. Rifai, and C. P. Cannon, “Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22),” American Journal of Cardiology, vol. 98, no. 7, pp. 861–865, 2006. View at Publisher · View at Google Scholar · View at Scopus
  148. C. Weber, W. Erl, A. Pietsch, U. Danesch, and P. C. Weber, “Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-α,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 15, no. 5, pp. 622–628, 1995. View at Google Scholar · View at Scopus
  149. E. S. R. Collie-Duguid and K. W. J. Wahle, “Inhibitory effect of fish oil n-3 polyunsaturated fatty acids on the expression of endothelial cell adhesion molecules,” Biochemical and Biophysical Research Communications, vol. 220, no. 3, pp. 969–974, 1996. View at Publisher · View at Google Scholar · View at Scopus
  150. D. I. Shaw, W. L. Hall, N. R. Jeffs, and C. M. Williams, “Comparative effects of fatty acids on endothelial inflammatory gene expression,” European Journal of Nutrition, vol. 46, no. 6, pp. 321–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  151. P. C. Calder, “N-3 polyunsaturated fatty acids, inflammation and immunity: pouring oil on troubled waters or another fishy tale?” Nutrition Research, vol. 21, no. 1-2, pp. 309–341, 2001. View at Publisher · View at Google Scholar · View at Scopus
  152. K. H. Ruan, V. Cervantes, and S. P. So, “Engineering of a novel hybrid enzyme: an anti-inflammatory drug target with triple catalytic activities directly converting arachidonic acid into the inflammatory prostaglandin E2,” Protein Engineering, Design and Selection, vol. 22, no. 12, pp. 733–740, 2009. View at Publisher · View at Google Scholar · View at Scopus